NCT06562257

Brief Summary

This study investigates the effectiveness of honey as a treatment for deep neck space abscesses, comparing it to standard wound care methods. Conducted as a randomized clinical trial, it aims to determine whether honey can offer a viable alternative or improvement in managing this condition. The research assesses outcomes related to healing, infection control, and overall patient recovery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 20, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

1.5 years

First QC Date

August 14, 2024

Last Update Submit

March 11, 2025

Conditions

Keywords

Deep neck space infectionDeep neck space abscessWound healingHoney dressingBates Jensen Wound Assessment Tool

Outcome Measures

Primary Outcomes (4)

  • Wound Assessment

    The wound was assessed by the research assistant using the Bates-Jensen Wound Assessment Tool

    BWATs was measured on the first, seventh, and fourteenth days from abscess incision.

  • Wound Measurements

    Wound measurements included length, width, and depth in cm, with the largest width and length used for data to report wound area in cm\^2. The wound depth was measured using a probe perpendicular to the wound's length and width.

    The wound was measured on the first, seventh, and fourteenth days from abscess incision.

  • Bacterial Colony

    Bacterial culture results and the number of bacterial colonies served as indicators of infection improvement. Swabs from the wound bed were sent to the Microbiology laboratory.

    Pus aspiration was performed by the resident doctor who conducted the dressing on the first and fourteenth days from abscess incision

  • Cytokine and Growth Factor Expression

    Immunopathological evaluation of wound healing involved tissue samples sent to the Anatomical Pathology laboratory for analysis of IL-1, TNF-α, and VEGF expression. Tissue sampling was performed using nasopharyngeal biopsy forceps, and the preserved tissue was sent for analysis.

    Tissue sampling was performed by the resident doctor who conducted the dressing on the first and fourteenth days from abscess incision

Secondary Outcomes (6)

  • Vital Sign Examinations

    Vital Signs were performed everyday throughout patient's admission in the wards.

  • Blood Gas Analysis

    Blood gas analysis were performed throughout patient's admission in the wards.

  • Complete Blood Count (CBC)

    CBC were performed throughout patient's admission in the wards.

  • Liver Function Tests

    Liver function tests were performed throughout patient's admission in the wards.

  • Kidney Function Tests

    Kidney function tests were performed throughout patient's admission in the wards.

  • +1 more secondary outcomes

Study Arms (2)

Treatment Group (Standard Dressing and Honey)

EXPERIMENTAL

In the treatment group, we combined standard procedures with the application of Nusantara Honey. A 120 cm gauze roll was soaked in a bowl containing 12 cc of Nusantara Honey for precisely 1 minute until saturation. Once the wound bed had risen sufficiently, the honey-soaked gauze was applied and covered with sterile gauze.

Other: HoneyOther: PHMB Solution

Control Group (Standard Dressing)

ACTIVE COMPARATOR

The control group adhered to the established standard operating procedure (SOP) at the Larynx Pharynx subdivision of Dr. Sardjito Hospital. This protocol involved several steps of wound debridement, saline irrigation, gauze roll application, and Prontosan administration.

Other: PHMB Solution

Interventions

HoneyOTHER

Honey has a long-standing reputation for promoting wound healing and offers a more economical treatment modality. Nusantara Honey, a GMP-certified product available on the market, met our criteria for quality and safety.

Also known as: Nusantara Honey
Treatment Group (Standard Dressing and Honey)

PHMB is an antimicrobial polymer that is effective against intracellular and biofilm forms of S. aureus. PHMB is quite effective in the treatment of wounds in deep neck abscesses.

Also known as: Prontosan
Control Group (Standard Dressing)Treatment Group (Standard Dressing and Honey)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Deep neck abscess patients over 18 years old with or without comorbidities except for malignant diseases

You may not qualify if:

  • Patients who refused intervention
  • Patients who underwent vacuum-assisted closure (VAC)
  • Patients with incomplete medical records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Sardjito General Hospital

Yogyakarta, D.I Yogyakarta, 55281, Indonesia

RECRUITING

Related Publications (1)

  • Wulandari DP, Subronto YW, Surono A. Honey as a Wound Care Modality in Treating Deep Neck Space Abscesses: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Aug 14;14:e75475. doi: 10.2196/75475.

MeSH Terms

Interventions

Honey

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Dian Paramita Wulandari

    Universitas Gadjah Mada - Dr. Sardjito General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dian Paramita Wulandari

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both patients and the principal investigator will remain blinded throughout the completed treatment period. Treatment allocations will only be disclosed after the final database lock. The patients are primarily handled by a principal investigator and resident doctor who is in charge of the evaluation of inclusion or exclusion criteria, adverse events, relapses, and side effects
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 20, 2024

Study Start

June 19, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations